Jacobs Bruce N. bought KYMR
May 18, 2026 · Form 4 insider transaction
Jacobs Bruce N. bought 15,000 shares of Kymera Therapeutics, Inc. at $2.08 per share, a transaction worth $31.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$2.08
Total value
$31.2K
InsiderJacobs Bruce N.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 18, 2026
Filing dateMay 19, 2026
Shares owned after247,588
OwnershipDirect
10b5-1 planNo
AmendedNo